Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Chinese Journal of Experimental and Clinical Virology ; (6): 345-347, 2008.
Article in Chinese | WPRIM | ID: wpr-254062

ABSTRACT

<p><b>OBJECTIVE</b>To explore the relationship between microsatellite alterations of RASSF1A gene and the development of cervical carcinoma, and HPV16 infection.</p><p><b>METHODS</b>Two sites of microsatellite polymorphism of RASSF1A gene were selected, we used polymerase chain reaction (PCR) technique to detect the LOH and MSI of cervical tissues, and to detect the infection state of HPV16.</p><p><b>RESULTS</b>There were significant differences of LOH rates at the two sites between clinical stage and pathological grade (P < 0.05). Significant differences were noted between the cervical carcinomas with lymph node metastasis and those without lymph node metastasis in regard to their LOH and MSI at the two sites ( P < 0.05). The incidence of LOH of RASSF1A gene was higher in HPV16(+) than that in HPV16(-) ( P < 0.05).</p><p><b>CONCLUSION</b>The change of RASSF1A gene is a relatively late event in cervical carcinomas. The detection of the LOH and MSI of RASSF1A gene might be helpful to the early diagnosis and the screening of cervical carcinoma. It might also be useful for predicting the prognosis of cervical carcinoma. Infection of HPV16 and LOH of RASSF1A gene had reacted together in the development of cervical carcinoma.</p>


Subject(s)
Female , Humans , Uterine Cervical Dysplasia , Diagnosis , Genetics , Gene Expression Regulation, Neoplastic , Loss of Heterozygosity , Genetics , Microsatellite Repeats , Genetics , NM23 Nucleoside Diphosphate Kinases , Genetics , Tumor Suppressor Proteins , Genetics , Uterine Cervical Neoplasms , Diagnosis , Genetics
2.
Chinese Medical Journal ; (24): 1247-1250, 2007.
Article in English | WPRIM | ID: wpr-280458

ABSTRACT

<p><b>BACKGROUND</b>Inhibition of the key costimulatory signals results in T cell anergy, indicating the alloantigen-specific immunologic unresponsiveness. In this study, the effect of blockage of costimulatory signal CD(86) on murine abortion-prone model was studied.</p><p><b>METHODS</b>Thirty CBA/J female mice cohabitated with DBA/2 male or BALB/c male mice were investigated. CBA/J x DBA/2 matings were used as the abortion-prone model, and CBA/J x BALB/c matings were used as the normal pregnant model. The abortion-prone models were divided into experimental and control groups, and the normal pregnant models were set as a normal group (10 mice in each group). The mice in the experimental group were treated with anti-mouse CD(86) monoclonal antibody (mAb) (100 microg) on day 4.5 of gestation, while the controls received irrelevant-isotype matched rat IgG(2b). As for the normal group, nothing was given to the mice. The mice were killed on day 13.5 of gestation, embryo resorption rate and the expression of transforming growth factor beta(1) (TGF-beta(1)), plasminogen activator inhibitor 1 (PAI-1), and matrix metalloproteinase 9 (MMP-9) were detected. Then the data were analyzed by Chi-square test and Fisher's exact test.</p><p><b>RESULTS</b>The embryo resorption rate in the experimental (8.2%) and normal groups (7.7%) was significantly lower than that of the control (23.5%, P < 0.05). No significant difference was detected between the experimental and normal groups (P > 0.05). The positive expression rates of TGF-beta(1) and PAI-1 proteins in the experimental and normal groups were significantly higher than those in the control group (P < 0.05). The positive expression rate of MMP-9 protein in the experimental and normal groups was significantly lower than that in the control group (P < 0.05). No significant difference in the positive expression rates of the three proteins was detected between the experimental and normal groups (P > 0.05).</p><p><b>CONCLUSIONS</b>Blockage of costimulatory signal CD(86) at early pregnancy can treat uncertain recurrent spontaneous abortion by stimulating the expression of TGF-beta(1), MMP-9 and PAI-1 and reducing the embryo resorption rate.</p>


Subject(s)
Animals , Female , Male , Mice , Pregnancy , Abortion, Habitual , Therapeutics , Antibodies, Monoclonal , Therapeutic Uses , B7-2 Antigen , Allergy and Immunology , Physiology , Embryo Loss , Immunohistochemistry , Matrix Metalloproteinase 9 , Mice, Inbred Strains , Plasminogen Activator Inhibitor 1 , Signal Transduction , Transforming Growth Factor beta1
SELECTION OF CITATIONS
SEARCH DETAIL